\u827e\u4f2f\u7ef4AbbVie\uff08NYSE:ABBV\uff09<\/a>\u7684\u9762\u524d\u6709\u4e00\u9053\u5927\u574e\uff1a2023\u5e741\u6708\u8d77\uff0c\u8be5\u516c\u53f8\u7684\u91cd\u78c5\u836f\u4fee\u7f8e\u4e50\u5728\u7f8e\u56fd\u5e02\u573a\u4e0a\u5c06\u9762\u4e34\u751f\u7269\u7c7b\u4f3c\u836f\u7684\u7ade\u4e89\u3002\u4fee\u7f8e\u4e50\u662f\u827e\u4f2f\u7ef4\u7684\u521b\u6536\u5927\u6237\uff1a2023\u5e74\u4e00\u5b63\u5ea6\u8d21\u732e\u4e86\u8be5\u516c\u53f8\u603b\u51c0\u6536\u5165\uff08122\u4ebf\u7f8e\u5143\uff09\u5f53\u4e2d\u768435\u4ebf\u7f8e\u5143\uff0c\u524d\u51e0\u5e74\u5360\u8be5\u516c\u53f8\u5e74\u9500\u552e\u989d\u7684\u6bd4\u4f8b\u66f4\u662f\u63a5\u8fd140%\u3002<\/p>\n\u4e3a\u4e86\u5e94\u5bf9\u8fd9\u4e00\u6311\u6218\uff0c\u827e\u4f2f\u7ef4\u8fc7\u53bb\u51e0\u5e74\u5f00\u5c55\u4e86\u591a\u8d77\u6218\u7565\u6027\u6536\u8d2d\uff0c\u6bd4\u5982\u8bf4Pharmacyclics\u7684\u8840\u764c\u836f\u7269Imbruvica\u4ee5\u53ca\u827e\u5c14\u5efa\u7684\u533b\u7f8e\u548c\u795e\u7ecf\u79d1\u5b66\u4e1a\u52a1\u3002\u4e0d\u8fc7\uff0c\u8fd9\u4e9b\u6536\u8d2d\u6216\u8bb8\u5e76\u4e0d\u8db3\u4ee5\u62b5\u6d88\u4fee\u7f8e\u4e50\u9500\u552e\u989d\u7684\u4e0b\u6ed1\u3002\u56e0\u6b64\uff0c2023\u5e74\u827e\u4f2f\u7ef4\u5fc5\u987b\u628a\u6536\u8d2d\u7ee7\u7eed\u4e0b\u53bb\u3002<\/p>\n
\u827e\u4f2f\u7ef4\u7684\u5e76\u8d2d\u524d\u666f<\/h2>\n
\u5236\u836f\u516c\u53f8\u6536\u8d2d\u65f6\u9700\u8981\u8003\u8651\u7684\u4e00\u4e2a\u5173\u952e\u56e0\u7d20\u662f\u76ee\u6807\u516c\u53f8\u4e0e\u5176\u6218\u7565\u76ee\u6807\u2014\u2014\u6bd4\u5982\u8bf4\u4e1a\u52a1\u62d3\u5c55\u5230\u65b0\u7684\u6cbb\u7597\u9886\u57df\uff0c\u5f3a\u5316\u81ea\u8eab\u7684\u7814\u53d1\u7ba1\u7ebf\uff0c\u6216\u8005\u662f\u62d3\u5bbd\u81ea\u5df1\u7684\u6536\u5165\u6d41\u2014\u2014\u662f\u5426\u4e00\u81f4\u3002\u7b2c\u4e00\u4e2a\u91cd\u8981\u7684\u56e0\u7d20\u662f\u76ee\u6807\u516c\u53f8\u4ea7\u54c1\u2014\u2014\u65e0\u8bba\u662f\u5904\u4e8e\u4e34\u5e8a\u5f00\u53d1\u9636\u6bb5\u6216\u8005\u5df2\u7ecf\u83b7\u6279\u5e76\u4e0a\u5e02\u2014\u2014\u7684\u5e02\u573a\u4ef7\u503c\u3002\u7b2c\u4e09\u4e2a\u56e0\u7d20\u662f\u6536\u8d2d\u516c\u53f8\u613f\u610f\u652f\u4ed8\u7684\u4ef7\u683c\uff0c\u8fd9\u53d6\u51b3\u4e8e\u8bf8\u5982\u7ade\u4e89\u5730\u4f4d\u3001\u6295\u8d44\u7684\u9884\u671f\u6536\u76ca\u7387\u4ee5\u53ca\u878d\u8d44\u7b49\u591a\u91cd\u56e0\u7d20\u3002<\/p>\n
\u5c31\u827e\u4f2f\u7ef4\u800c\u8a00\uff0c\u8be5\u516c\u53f8\u4e1a\u52a1\u8986\u76d6\u514d\u75ab\u3001\u80bf\u7624\u3001\u533b\u7f8e\u3001\u795e\u7ecf\u7cfb\u7edf\u79d1\u5b66\u548c\u773c\u90e8\u62a4\u7406\uff0c\u56e0\u6b64\u6536\u8d2d\u76ee\u6807\u7684\u8303\u56f4\u4e5f\u5f88\u5e7f\u3002\u4e8e\u662f\uff0c\u4ef7\u683c\u5c31\u6210\u4e3a\u5173\u952e\u8981\u7d20\u3002\u827e\u4f2f\u7ef4\u53ef\u4ee5\u82b1100\u4ebf\u7f8e\u5143\u6536\u8d2d\u800c\u4e0d\u4f1a\u5bf9\u5176\u8d44\u4ea7\u8d1f\u503a\u8868\u9020\u6210\u8d1f\u9762\u5f71\u54cd\uff0c\u4f46\u5982\u679c\u4ea4\u6613\u91d1\u989d\u5230\u4e86200\u4ebf\u7f8e\u5143\u751a\u81f3\u66f4\u9ad8\u53ef\u80fd\u5c31\u4e0d\u592a\u53ef\u884c\u4e86\uff0c\u6bd5\u7adf\u8be5\u516c\u53f8\u7684\u8d1f\u503a\u6c34\u5e73\u9ad8\uff0c\u540c\u65f6\u6536\u8d2d\u53ef\u80fd\u906d\u9047\u6765\u81ea\u7f8e\u56fd\u8054\u90a6\u8d38\u6613\u59d4\u5458\u4f1a\uff08FTC\uff09\u7684\u963b\u529b\u3002<\/p>\n
\u4e24\u4e2a\u9884\u7b97\u53cb\u597d\u7684\u6536\u8d2d\u76ee\u6807<\/h2>\n
\u5728\u4e0a\u8ff0\u4ef7\u683c\u533a\u95f4\u5185\uff0cBlueprint Medicines Corp\uff08NASDAQ:BPMC\uff09\u548cKrystal Biotech Inc.\uff08NASDAQ:KRYS\uff09\u8fd9\u4e24\u53ea\u4e2d\u7b49\u5e02\u503c\u7684\u5236\u836f\u5546\u6700\u6709\u53ef\u80fd\u6210\u4e3a\u827e\u4f2f\u7ef4\u7684\u6536\u8d2d\u76ee\u6807\u3002<\/p>\n
Blueprint\u662f\u4e00\u5bb6\u805a\u7126\u4e8e\u764c\u75c7\u6cbb\u7597\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u76ee\u524d\u5e02\u503c\u7ea638\u4ebf\u7f8e\u5143\u5e76\u4e14\u624b\u63e1\u4e24\u4e2a\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7ba1\u5c40\uff08FDA\uff09\u83b7\u6279\u836f\u7269\uff1a\u6cbb\u7597\u665a\u671f\u6216\u60f0\u6027\u7cfb\u7edf\u6027\u80a5\u5927\u7ec6\u80de\u589e\u591a\u75c7\u7684Ayvakit\uff0c\u4ee5\u53ca\u6cbb\u7597\u665a\u671f\u6216\u8f6c\u79fb\u6027RET\u7a81\u53d8\u7532\u72b6\u817a\u9ad3\u6837\u764c\u548c\u8f6c\u79fb\u6027RET\u878d\u5408\u9633\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u7684Gavreto\u3002\u4e0d\u8fc7\uff0cBlueprint\u4f5c\u4e3a\u6536\u8d2d\u5019\u9009\u516c\u53f8\u7684\u4e3b\u8981\u5438\u5f15\u529b\u5728\u4e8e\u5b83\u7684\u5b9e\u4f53\u7624\u521d\u671f\u7814\u53d1\u836f\u7269\u3002\u827e\u4f2f\u7ef4\u6709\u53ef\u80fd\u4ee550-55\u4ebf\u7f8e\u5143\u4e4b\u95f4\u7684\u4ef7\u683c\u6536\u8d2d\u8fd9\u5bb6\u7cbe\u51c6\u80bf\u7624\u516c\u53f8\u3002<\/p>\n
Krystal Biotech\u662f\u4e00\u5bb6\u805a\u7126\u4e8e\u7f55\u89c1\u76ae\u80a4\u75c5\u7684\u57fa\u56e0\u6cbb\u7597\u516c\u53f8\uff0c\u5e76\u4e14\u6700\u8fd1\u8be5\u516c\u53f8\u6cbb\u7597\u8425\u517b\u4e0d\u826f\u578b\u5927\u75b1\u6027\u8868\u76ae\u677e\u89e3\u75c7\u7684\u5916\u7528\u57fa\u56e0\u7597\u6cd5Vyjuvek\u83b7\u5f97FDA\u6279\u51c6\u3002\u6309\u7167\u534e\u5c14\u8857\u5206\u6790\u5e08\u7684\u4f30\u7b97\uff0cVyjuvek\u5728\u7f8e\u56fd\u7684\u5e74\u9500\u552e\u989d\u6709\u671b\u7a81\u78347.50\u4ebf\u7f8e\u5143\uff0c\u5168\u7403\u7684\u5cf0\u503c\u9500\u552e\u989d\u6216\u8d85\u8fc711\u4ebf\u7f8e\u5143\u3002\u6b64\u5916\uff0cKrystal\u8fd8\u6709\u5176\u4ed6\u5f88\u591a\u5904\u4e8e\u4e34\u5e8a\u524d\u6216\u521d\u671f\u7684\u76ae\u80a4\u533b\u5b66\u7814\u53d1\u9879\u76ee\uff0c\u5e76\u4e14\u79ef\u6781\u63a2\u7d22\u7f55\u89c1\u547c\u5438\u7cfb\u7edf\u75be\u75c5\u4ee5\u53ca\u533b\u7f8e\u9886\u57df\u7684\u57fa\u56e0\u7597\u6cd5\u3002\u827e\u4f2f\u7ef4\u6709\u53ef\u80fd\u4ee5\u4e0d\u8d85\u8fc750\u4ebf\u7f8e\u5143\u7684\u4ef7\u683c\u6536\u8d2d\u8be5\u516c\u53f8\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u75af\u72c2\u5e76\u8d2d\uff0c\u60c5\u975e\u5f97\u5df2\uff1f \u5927\u578b\u5236\u836f\u5546\u827e\u4f2f\u7ef4AbbVie\uff08NYSE:ABBV\uff09\u7684\u9762\u524d\u6709\u4e00\u9053\u5927\u574e\uff1a2023\u5e741\u6708\u8d77\uff0c\u8be5 […]<\/p>\n","protected":false},"author":27,"featured_media":408486,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[455,747,766,459],"class_list":["post-465337","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-455","tag-747","tag-766","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/465337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=465337"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/465337\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/408486"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=465337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=465337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=465337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}